iBio (IBIO) EBITDA (2010 - 2026)
iBio's (IBIO) quarterly EBITDA came in at -$8.4 million in Q1 2026, down 71.45% year-on-year from -$29.3 million in Q1 2025, and up 11.43% on a QoQ basis from -$9.4 million in Q4 2025.
iBio (IBIO) EBITDA (2010 - 2026) Analysis & Trends
iBio (IBIO) has 17 years of EBITDA data on file, last reported at -$8.4 million in Q1 2026.
- On a quarterly basis, EBITDA fell 71.45% year-over-year to -$8.4 million in Q1 2026; TTM through Mar 2026 was -$29.0 million, a 72.24% decrease from a year earlier, with the FY2025 full-year figure at -$18.6 million, down 11.83% from the prior year.
- EBITDA for Q1 2026 stood at -$8.4 million, up from -$9.4 million in the prior quarter.
- Over the last five years, EBITDA for IBIO reached as high as -$3.4 million in Q2 2024 and fell as low as -$10.6 million in Q4 2022.
- Historically, EBITDA has averaged -$6.2 million across 5 years, with a median of -$5.2 million in 2025.
- Across the five-year window, EBITDA jumped 57.48% in 2023 and sank 113.74% in 2025, its largest moves.
- Year by year, EBITDA stood at -$10.6 million in 2022, then soared by 57.48% to -$4.5 million in 2023, then gained by 1.71% to -$4.4 million in 2024, then slumped by 113.74% to -$9.4 million in 2025, then rose by 11.43% to -$8.4 million in 2026.
- Per Business Quant data, the three most recent EBITDA figures were -$8.4 million in Q1 2026, -$9.4 million in Q4 2025, and -$6.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,861.65 Bn | 66,861.36 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,911.83 Bn | 1,911.77 Bn | - | - |
| 3 | Akari Therapeutics | 973.81 Bn | 973.81 Bn | - | -15.76 Mn |
| 4 | BeOne Medicines | 471.51 Bn | 466.72 Bn | 1.35 Bn | 249.90 Mn |
| 5 | Vertex Pharmaceuticals | 121.94 Bn | 114.70 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.30 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.68 Bn | 62.68 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 55.88 Bn | 50.69 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Alnylam Pharmaceuticals | 37.49 Bn | 34.48 Bn | 959.66 Mn | 268.64 Mn |
| 10 | iBio | 165.65 Mn | 165.65 Mn | - | -8.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.37 Mn |
| Dec 31, 2025 | -9.45 Mn |
| Sep 30, 2025 | -5.95 Mn |
| Jun 30, 2025 | -5.20 Mn |
| Mar 31, 2025 | -4.88 Mn |
| Dec 31, 2024 | -4.42 Mn |
| Sep 30, 2024 | -4.11 Mn |
| Jun 30, 2024 | -3.41 Mn |
| Mar 31, 2024 | -3.63 Mn |
| Dec 31, 2023 | -4.50 Mn |
| Sep 30, 2023 | -5.10 Mn |
| Jun 30, 2023 | -4.97 Mn |
| Mar 31, 2023 | -6.17 Mn |
| Dec 31, 2022 | -10.57 Mn |
| Sep 30, 2022 | -7.64 Mn |
| Jun 30, 2022 | -10.45 Mn |
| Mar 31, 2022 | -6.79 Mn |
| Dec 31, 2021 | -7.23 Mn |
| Sep 30, 2021 | -5.23 Mn |
| Jun 30, 2021 | -9.44 Mn |